Advertisement
Ascendis Pharma A/S

ASND News Today: Stay Updated with the Latest Ascendis Pharma A/S News in Real Time

Find ASND news now at Meyka AI. Stay informed with the latest{" "} Ascendis Pharma A/S stocks updates, including price news, market analysis, and expert insights.

ASNDNASDAQ
HealthcareBiotechnology
$218.84
$2.05(0.95%)
U.S. Market opens in 16h 5m
Advertisement
Nifty 50 EPS Cuts: Cipla, L&T, Adani Enterprises & Adani Ports Among 31 Downgraded Stocks in FY27 Forecast
📅 9 hours ago

Nifty 50 EPS Cuts: Cipla, L&T, Adani Enterprises & Adani Ports Among 31 Downgraded Stocks in FY27 Forecast

Earnings expectations for India’s top companies are facing fresh pressure. In May 2026, analysts lowered FY27 earnings-per-share (EPS) forecasts for 31 of the 50 companies in the Nifty 50 index, highlighting growing concerns about profit growth across key sectors. Major names such as Cipla, L&T, Adani Enterprises, and Adani Ports were among those affected. The…

Read more 12
Hang Seng Index Eyes 28,000 as Analysts Favor AI and Healthcare
📅 2 days ago

Hang Seng Index Eyes 28,000 as Analysts Favor AI and Healthcare

Everbright Securities targets Hang Seng Index at 28,000 points in H2 2026, favoring AI, healthcare, and consumer stocks amid China’s policy support.

Read more 12
Wockhardt Shares Fall Over 8% as Investors Book Profits After 50% Rally 
📅 2 days ago

Wockhardt Shares Fall Over 8% as Investors Book Profits After 50% Rally 

Shares of Wockhardt saw a sharp fall of over 8% in recent trading. The drop came right after a strong rally of nearly 50% in just a few sessions. We are seeing a classic market move here. Fast gains. Then, quick profit booking. No major negative news triggered the fall. Instead, investors simply locked in…

Read more 12
Swiss SMI Drops 1.75% on Iran Tensions, Pharma Stocks Fall
📅 2 days ago

Swiss SMI Drops 1.75% on Iran Tensions, Pharma Stocks Fall

Swiss SMI index fell 1.75% to 13,305.40 on June 1 amid U.S.-Iran tensions. Pharma stocks dropped over 3% despite strong retail sales.

Read more 12
Nifty 50 Falls 1.5% on Monsoon Concerns and MSCI Rebalancing, May 30
📅 5 days ago

Nifty 50 Falls 1.5% on Monsoon Concerns and MSCI Rebalancing, May 30

Nifty 50 falls 1.5% to 23,547 on May 29 amid monsoon concerns, MSCI rebalancing, and profit-taking after April’s 7.5% surge. Sensex down 1.44%.

Read more 12
India’s Stock Market Falls 1.5% on Monsoon Fears and Iran Tensions, May 30
📅 6 days ago

India’s Stock Market Falls 1.5% on Monsoon Fears and Iran Tensions, May 30

NSE Nifty fell 1.5% to 23,547.75 and BSE Sensex dropped 1.44% to 74,775.74 on May 29 amid monsoon concerns, FII selling, and MSCI rebalancing.

Read more 12
Weekly Market Wrap: NIFTY50 Gains 0.3%, SENSEX Ends Higher; Grasim Industries and Wipro Lead Rally
📅 12 days ago

Weekly Market Wrap: NIFTY50 Gains 0.3%, SENSEX Ends Higher; Grasim Industries and Wipro Lead Rally

The NIFTY50 ended the week on a mildly positive note, gaining 0.3% in the week ended Friday, May 22, 2026. The index added 75.80 points and closed at 23,719.30. The BSE SENSEX also moved higher, rising 0.24% or 177.36 points to settle at 75,415.35. These gains were modest, but they mattered because the broader market…

Read more 12
Innate Pharma Stock Tumbles 16.3% as Biotech Faces Clinical Trial Headwinds
📅 13 days ago

Innate Pharma Stock Tumbles 16.3% as Biotech Faces Clinical Trial Headwinds

IPH.PA stock drops 16.3% to €1.64 on EURONEXT. Innate Pharma faces clinical trial delays and cash burn concerns in oncology pipeline.

Read more 12
BetterLife Pharma Inc. Stock Drops 7.7% as BETR.CN Faces Earnings Test
📅 13 days ago

BetterLife Pharma Inc. Stock Drops 7.7% as BETR.CN Faces Earnings Test

BETR.CN stock falls 7.7% to C$0.06 ahead of May 27 earnings. Biotech firm develops neurological disorder treatments.

Read more 12

ASND News FAQ